The CSRC's Review Approach to the 'Historical Evolution' of an Offshore Applicant

The People’s Bank of China and the China Securities Regulatory Commission (CSRC) have, since the second half of 2024, intensified their joint oversight of offshore listings, a shift that has fundamentally altered the documentary burden on applicants. The critical pivot point was the December 2023 issuance of the Administrative Provisions on Overseas Securities Offering and Listing by Domestic Companies (the “Overseas Listing Rules”), which became fully effective on 1 January 2024. Under these rules, the CSRC now requires a detailed, chronological “historical evolution” narrative for any offshore applicant with a PRC nexus, tracing its corporate structure from inception to the date of filing. This requirement, codified in Article 8 of the Trial Administrative Measures for Overseas Securities Offering and Listing by Domestic Companies (the “Trial Measures”), is not a mere procedural formality. It is a substantive review mechanism designed to detect undisclosed VIE arrangements, unapproved red-chip restructurings, and historical violations of PRC foreign investment laws. For a firm seeking a dual listing on the Hong Kong Stock Exchange (HKEX) and a US exchange, the stakes are high: a single gap in this narrative can trigger a formal comment letter from the CSRC, delaying the prospectus filing by 60 to 120 business days, as evidenced by the 2024 filings of at least three large-cap consumer technology companies. This article dissects the CSRC’s evolving review approach to this historical evolution, providing a framework for sponsors, legal counsel, and compliance officers to navigate this regulatory terrain.

The Regulatory Basis and Scope of the Historical Evolution Review

The CSRC’s authority to demand a historical evolution analysis stems directly from the Overseas Listing Rules, which apply to all domestic companies seeking to list securities on overseas markets, including via a special purpose vehicle (SPV) in the Cayman Islands or Bermuda. The scope of this review is deliberately broad, covering not only the applicant itself but also its PRC operating entities, the SPV, and any intermediate holding companies in jurisdictions such as the BVI or Hong Kong.

The Statutory Foundation: Article 8 of the Trial Measures

Article 8 of the Trial Administrative Measures for Overseas Securities Offering and Listing by Domestic Companies (CSRC Order No. 2, 2023) explicitly states that an applicant must submit a “written explanation of the historical evolution of the offshore structure and the domestic operating entities.” This is not a simple corporate timeline. The CSRC expects a narrative that identifies every material change in shareholding, every transfer of equity or assets, and every modification to the VIE or direct ownership structure. The review period is not limited to the three years preceding the filing; it extends to the entire life of the corporate group, including any predecessor entities. For example, if a PRC operating entity was originally a wholly foreign-owned enterprise (WFOE) that later converted to a VIE structure, the CSRC will require documentation of the original foreign investment approval, the conversion rationale, and any subsequent amendments to the VIE agreements. Failure to provide this can result in a formal inquiry under Article 12, which allows the CSRC to request supplementary materials or even suspend the filing.

The VIE Structure as a Trigger for Heightened Scrutiny

The CSRC’s historical evolution review is particularly rigorous for applicants employing a Variable Interest Entity (VIE) structure. Under the Overseas Listing Rules, a VIE arrangement must be disclosed in the prospectus and the historical evolution narrative must demonstrate that the VIE was established in compliance with PRC foreign investment restrictions. The CSRC will cross-reference the timeline of VIE creation against the Special Administrative Measures (Negative List) for Foreign Investment Access (2021 edition). If the VIE was established after the Negative List prohibited foreign investment in the relevant sector (e.g., value-added telecommunications services), the CSRC may deem the structure non-compliant. In 2024, the CSRC issued at least four comment letters to offshore applicants questioning the historical legality of their VIE structures, specifically citing the date of the Negative List amendment. The regulator’s approach is to treat the historical evolution as a compliance audit, not a mere disclosure exercise.

The Role of the Sponsor in Documenting the Narrative

The sponsor (保薦人) is now required to certify the accuracy of the historical evolution narrative under Article 16 of the Trial Measures. This places a due diligence burden on the sponsor to verify every material corporate event. The CSRC has, in its 2024 review practice, demanded that sponsors provide supporting documentation for each step, including board resolutions, share purchase agreements, and PRC regulatory approvals (e.g., from the Ministry of Commerce or the National Development and Reform Commission). For a dual-listing applicant, the sponsor must also reconcile the historical evolution narrative with the HKEX Listing Rules requirements under Chapter 9 (Equity Securities) and Chapter 19A (PRC Issuers). The CSRC’s review is not limited to PRC law; it will also examine whether the offshore incorporation in the Cayman Islands or Bermuda was conducted in accordance with the laws of that jurisdiction, including the filing of annual returns and the maintenance of statutory registers.

Key Areas of Scrutiny: Share Transfers, Capital Injections, and Red-Chip Restructurings

The CSRC’s historical evolution review focuses on three principal areas: the timing and pricing of share transfers, the source and legality of capital injections, and the mechanics of any red-chip restructuring. Each of these areas carries specific documentary requirements that, if unmet, can stall the filing.

Share Transfers: Pricing and Tax Compliance

The CSRC will examine every share transfer in the history of the offshore applicant and its PRC operating entities. The key concern is whether the transfer price reflects fair market value and whether the transferor paid the applicable PRC capital gains tax under the Enterprise Income Tax Law (EIT Law). For transfers occurring after 1 January 2008, when the EIT Law took effect, the CSRC expects evidence of tax filing and payment. If the transfer involved a non-resident enterprise (e.g., a BVI holding company), the CSRC will require documentation of the 10% withholding tax under Article 3 of the EIT Law. In 2024, the CSRC issued a comment letter to a Hong Kong-listed applicant questioning a 2019 share transfer among BVI entities, demanding evidence that the transfer was reported to the local tax authority. The regulator’s approach is to treat any unexplained price deviation (e.g., a transfer at par value when the company’s net asset value was significantly higher) as a red flag for potential tax evasion or undisclosed related-party transactions.

Capital Injections: Source of Funds and Foreign Exchange Compliance

The CSRC requires a detailed breakdown of the source of funds for every capital injection into the offshore SPV and the PRC WFOE. This is governed by the Provisions on the Administration of Foreign Exchange (2019 revision) and the SAFE Circular 37 (2014). For a capital injection from a PRC resident (e.g., a founder who established the offshore SPV), the CSRC will demand evidence that the resident obtained SAFE registration under Circular 37. If the capital injection originated from an offshore entity (e.g., a venture capital fund in the Cayman Islands), the CSRC will require proof that the funds were remitted through proper banking channels and that the PRC WFOE obtained a Foreign Investment Registration Certificate from the Ministry of Commerce. In 2024, the CSRC rejected the filing of a fintech applicant because its historical capital injections from a BVI entity lacked documentation of the SAFE registration for the PRC resident shareholders. The regulator’s position is that any capital injection that cannot be traced to a legitimate source is presumptively illegal.

Red-Chip Restructurings: The “Round-Trip” Investment Test

The CSRC’s review of red-chip restructurings is the most stringent. Under the Overseas Listing Rules, a red-chip restructuring (i.e., the transfer of PRC operating assets to an offshore SPV) must comply with the Regulations on Foreign Exchange Control of Round-Trip Investment by Residents (SAFE Circular 37). The CSRC will examine whether the restructuring was approved by the PRC authorities at the time it occurred. For restructurings that took place before the 2014 issuance of Circular 37, the CSRC will accept a retrospective filing, but only if the applicant can demonstrate that no PRC laws were violated. In practice, the CSRC has, since 2024, required a “clean” opinion from a qualified PRC law firm for any restructuring that involved a transfer of assets from a PRC entity to an offshore SPV. The law firm must confirm that the restructuring did not violate the Company Law (2018 revision) or the Foreign Investment Law (2020). If the restructuring involved a VIE, the CSRC will also require a legal opinion on the enforceability of the VIE agreements under PRC contract law.

Practical Implications for Filing and Disclosure Strategy

The CSRC’s historical evolution review has direct implications for the timing and content of the prospectus filing. Applicants must now budget for a longer pre-filing period and a more detailed disclosure strategy.

The Impact on Filing Timelines

The CSRC’s review of the historical evolution can add 60 to 120 business days to the filing process, depending on the complexity of the corporate structure. For a standard offshore applicant with a direct WFOE structure and no VIE, the review may take 30 to 45 business days. For a complex structure involving multiple BVI holding companies, a Cayman SPV, and a VIE, the review can extend to 90 to 120 business days. This timeline is consistent with the CSRC’s 2024 practice, as reported in the filings of three consumer technology companies that received comment letters specifically on their historical evolution narratives. Sponsors should factor this into the overall IPO timeline, particularly for a dual listing where the HKEX and SEC timelines must be synchronized.

Disclosure Strategy: Proactive vs. Reactive

The CSRC’s approach favors proactive disclosure. An applicant that voluntarily identifies and explains a historical compliance gap (e.g., a missing SAFE registration) is more likely to receive a favorable review than one that attempts to omit the issue. The Trial Measures Article 12 allows the CSRC to request supplementary materials, but a proactive disclosure can avoid a formal comment letter. For example, if a founder failed to obtain SAFE registration for a 2015 capital injection, the applicant should disclose this in the historical evolution narrative and provide evidence of a subsequent filing with the State Administration of Foreign Exchange. The CSRC has, in 2024, accepted such retrospective filings for applicants that demonstrated good faith. The key is to frame the disclosure as a compliance remediation, not a violation.

The Role of the PRC Law Firm Opinion

The CSRC now expects a legal opinion from a qualified PRC law firm that specifically addresses the historical evolution. This opinion must be submitted as part of the filing package under Article 7 of the Trial Measures. The opinion should cover the legality of every share transfer, capital injection, and restructuring event. The law firm must confirm that the historical evolution complies with PRC laws in effect at the time of each event. For a VIE structure, the opinion must also address the enforceability of the VIE agreements under PRC law, including the Contract Law (2020 revision) and the Civil Code (2021). The CSRC has, in its 2024 review, rejected legal opinions that were too generic (e.g., stating that the structure “generally complies” without specific citations). The opinion must be precise, referencing the exact legal provisions and the dates of compliance.

Actionable Takeaways

1. Audit the full lifecycle: The CSRC’s review covers the entire history of the offshore structure and its PRC operating entities, not just the three years preceding the filing; any gap in documentation for a share transfer, capital injection, or restructuring can trigger a formal comment letter and a 60-120 business day delay.
2. Proactively remediate SAFE and tax compliance: For any historical capital injection or share transfer involving a PRC resident, obtain a retrospective SAFE Circular 37 registration and evidence of capital gains tax payment under the EIT Law before submitting the filing.
3. Commission a detailed PRC law firm opinion: The legal opinion must cite specific PRC laws (e.g., Company Law, Foreign Investment Law, Contract Law) and confirm compliance at the time of each event; generic statements of “general compliance” will be rejected.
4. Prepare a VIE-specific narrative: If the applicant uses a VIE structure, the historical evolution must demonstrate that the VIE was established in compliance with the Negative List in effect at the time and that the VIE agreements are enforceable under PRC contract law.
5. Budget for a longer pre-filing period: For a complex offshore structure with multiple jurisdictions and a VIE, allocate at least 90 to 120 business days for the CSRC’s historical evolution review, and synchronize this with the HKEX and SEC filing timelines.